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Surgical Ligation of Patent Ductus Arteriosus
in Very-low-birth-weight Premature Infants 
in the Neonatal Intensive Care Unit
Yu-Chen Ko,1 Chung-I Chang,1* Ing-Sh Chiu,1 Yih-Sharn Chen,1 Shu-Chien Huang,1
Wu-Shiun Hsieh2
This study reported our experience of bedside patent ductus arteriosus (PDA) ligation for prematurity in
the neonatal intensive care unit (NICU). Between April 1992 and March 2006, 41 very-low-birth-weight
premature infants underwent PDA ligation in the NICU. There were 18 male and 23 female infants. The
mean gestational age and birth weight were 26.9 weeks and 900.9 g, respectively. Preoperatively, 25 infants
were ventilator-dependent. After operation, there were five deaths caused by complications of prematurity.
Surgical complications occurred in four and all recovered well after treatment. Twenty preoperatively intu-
bated babies survived and were extubated at 21.6 ± 12.7 days postoperatively. In conclusion, bedside PDA
ligation in the NICU is safe and effective. It can avoid transportation of critically ill, very small infants. 
We suggest surgical closure as the primary treatment in very-low-birth-weight infants who are ventilator-
dependent to avoid the possible complications of indomethacin and prolonged intubation. [J Formos Med
Assoc 2009;108(1):69–71]
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BRIEF COMMUNICATION
Patent ductus arteriosus (PDA) is a common dis-
ease in very-low-birth-weight premature infants
(i.e. birth weight ≤ 1500 g).1 Symptomatic PDA
should be closed as early as possible.2,3 Indometh-
acin has been the first choice of treatment. If it
fails, surgical ligation is the definitive therapy.4,5
The critically ill infants are usually intubated and
need several monitoring and drug-infusion lines.
To eliminate the risks associated with transporta-
tion, some centers perform the operation in the
neonatal intensive care unit (NICU).2,6 Herein,
we report our experience of PDA ligation in 
the NICU.
Methods
Between April 1992 and March 2006, 41 very-
low-birth-weight premature infants underwent
PDA ligation in the NICU. There were 18 male
and 23 female infants. The mean gestational age
was 26.9 weeks (range, 23–34 weeks). The mean
birth weight was 900.9 g (range, 578–1500 g).
Also, there were 30 infants who weighed ≤ 1000 g
at birth, with a mean gestational age of 26.1 weeks
in this study (Table 1).
Indomethacin therapy was first attempted in
37 patients, except in four with contraindications
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prior to surgery (2 with intraventricular hemor-
rhage and thrombocytopenia, 1 with renal failure,
1 with necrotizing enterocolitis). Preoperatively,
25 infants were ventilator-dependent and had
congestive heart failure. The mean age at ligation
was 31.1 days.
PDA ligation was performed at the bedside in
the NICU by a team that consisted of the opera-
tor, an assistant surgeon, an anesthetist, a scrub
nurse, a circulating nurse, and the neonatal 
intensive care specialist. Following anesthesia,
the patient was put in the right lateral decubitus
position. After thoracotomy, the lung was re-
tracted anteriorly. The ductus was identified and
ligated with two strands of 2-O silk or 3-O
Ticron (Sherwood, Davis & Geck, St Louis, MO,
USA). Hemoclips were used in two patients. An
8- or 10-Fr chest tube was inserted routinely in
all cases.
Results
There were five inhospital deaths (Table 2). They
were all ventilator-dependent preoperatively. All
the deaths were attributed to the complications
of prematurity and preoperative congestive heart
failure. Surgical complications occurred in four
patients: right lower lobe collapse, intraoperative
blood loss > 5 mL, chylothorax and pneumome-
diastinum. All of them recovered well after con-
servative treatment.
Preoperatively, 37 patients received indometh-
acin therapy. Renal insufficiency occurred in five
patients, gastrointestinal bleeding in four, sus-
pected necrotizing enterocolitis in two, and intra-
ventricular hemorrhage in one. PDA was reopened
in one patient. The mean age at operation was
32.4 ± 17.2 days in the 37 patients who received
indomethacin therapy, and 19.7 ± 8.7 days in the
four patients who did not receive indomethacin
therapy. All the mortality was in the indomethacin
group.
There were 25 patients who were ventilator-
dependent prior to operation. Excluding the five
who died, extubation was successful in the 20 sur-
viving patients at 21.6 ± 12.7 days after operation.
Thirty-six infants were discharged from our
hospital. There was no late complication regarding
PDA ligation, with a mean follow-up of 3.7 years.
Discussion
Currently, surgical closure of PDA is reserved for
infants who do not respond to medical manage-
ment, including indomethacin therapy. The suc-
cess rate of indomethacin therapy for PDA closure
is 79% if birth weight is < 1750 g.5 However, the
failure rate is up to 40–50% if birth weight is
< 800 g.7 Meanwhile, indomethacin may increase
the incidence of necrotizing enterocolitis and
bowel perforation in extremely premature in-
fants.8 These side effects cannot be tolerated by
critically ill infants. Surgical ligation should be
thought of as the primary form of treatment in
very premature neonates.8,9
One randomized study has demonstrated
that early surgical closure of PDA is beneficial in
preterm infants weighing < 1500 g who require
ventilatory support.10 Even though some studies
have revealed that there is no significant differ-
ence in the survival rate between indomethacin
and surgical ligation, the complications of indo-
methacin treatment and prolonged intubation
have been shown to have a significant impact on
surgical outcome.11 Congestive heart failure 
induced by PDA may compromise the general
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Table 1. Clinical data of 41 premature infants who
underwent surgery for patent ductus
arteriosus
Infants (n)
Birth weight (g)
≤ 750 13
751–1000 17
> 1000–1500 11
Gestational age (wk)
≤ 25 12
26–30 23
31–34 6
condition of the premature neonate.11 To de-
crease the complications of PDA, we suggest
early closure of PDA by surgery instead of med-
ical treatment in very-low-birth-weight premature
infants.
Our study shows that it is safe and effective to
perform bedside PDA ligation in the NICU. It
can avoid the risks associated with transporta-
tion of critically ill very small infants. In our
study, there were no deaths related to the proce-
dure. Surgical closure should be considered as
the primary choice of treatment for very-low-birth-
weight infants, to avoid the possible complications
of indomethacin treatment and prolonged 
intubation.
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Table 2. Cause of mortality in five patients
Infant Sex
GA BBW
Preoperative condition
Survival after 
Cause of death
(wk) (g) surgery (d)
1 F 28 934 Respiratory distress, fever, leukocytosis 55 Sepsis
2 M 27 746 ARF after indomethacin; dopamine & 142 Hypoxic encephalopathy after CPR 
dobutamine for severe heart failure (5 mo after operation)
3 M 24 650 IV dobutamine for severe heart failure, 19 Shock before operation
hypotension, desaturation
4 M 25 682 Heart failure 87 IVH, CLD, respiratory failure
5 M 25 750 Heart failure 100 Bowel perforation, ileus, cholestasis
GA = gestational age; BBW = birth body weight; ARF = acute renal failure; CPR = cardiopulmonary resuscitation; IV = intravenous; IVH = intraventricular
hemorrhage; CLD = chronic lung disease.
